+Compare
BBP
ETF ticker: NYSE ARCA
AS OF
Loading...
Price
Loading...
Change
Loading...
Net Assets
15.73M

BBP Virtus LifeSci Biotech Products ETF Forecast, Technical & Fundamental Analysis

Category Health
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for BBP with price predictions
07:00 PM EST Nov 30, 2023

Aroon Indicator for BBP shows an upward move is likely

BBP's Aroon Indicator triggered a bullish signal on December 01, 2023. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 225 similar instances where the Aroon Indicator showed a similar pattern. In of the 225 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 22, 2023. You may want to consider a long position or call options on BBP as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BBP just turned positive on November 01, 2023. Looking at past instances where BBP's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

BBP moved above its 50-day moving average on November 17, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BBP crossed bullishly above the 50-day moving average on November 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBP advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BBP broke above its upper Bollinger Band on November 30, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Intra-Cellular Therapies (NASDAQ:ITCI), BioCryst Pharmaceuticals (NASDAQ:BCRX).

Industry description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

Market Cap

The average market capitalization across the Virtus LifeSci Biotech Products ETF ETF is 10.35B. The market cap for tickers in the group ranges from 92.14M to 141.43B. AMGN holds the highest valuation in this group at 141.43B. The lowest valued company is TSVT at 92.14M.

High and low price notable news

The average weekly price growth across all stocks in the Virtus LifeSci Biotech Products ETF ETF was 5%. For the same ETF, the average monthly price growth was 10%, and the average quarterly price growth was -2%. IMGN experienced the highest price growth at 83%, while ADMA experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Virtus LifeSci Biotech Products ETF ETF was 217%. For the same stocks of the ETF, the average monthly volume growth was 15% and the average quarterly volume growth was 65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 81
Price Growth Rating: 53
SMR Rating: 87
Profit Risk Rating: 82
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
501 Madison Avenue, Suite 501New YorkNew York
Phone
(212) 593-4383
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXBMF0.990.03
+2.61%
Calibre Mining Corp
MBGAF65.550.40
+0.61%
Mercedes Benz Group AG
XISHY11.38-0.09
-0.78%
Xinyi Solar Holdings Ltd
TSCDY10.63-0.16
-1.48%
Tesco PLC
QIND0.18N/A
-2.70%
Quality Industrial Corp

BBP and

Correlation & Price change

A.I.dvisor tells us that BBP and XBI have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBP and XBI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBP
1D Price
Change %
BBP100%
+2.25%
XBI - BBP
13%
Poorly correlated
+3.06%
IBB - BBP
12%
Poorly correlated
+1.38%
IHI - BBP
12%
Poorly correlated
+1.24%
VHT - BBP
12%
Poorly correlated
+0.65%
XLV - BBP
9%
Poorly correlated
+0.40%